GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Results] 55 weeks on 5mg, full numbers, ask me anything boring — 10 comments in the full submission. View in context.
143
c/orforglipron·submitted 3 months ago by u/tidy_vialdrawer_watch28

[Results] 55 weeks on 5mg, full numbers, ask me anything boring

Trial Databranch of 6 comments

Reporting in. 55 weeks on 5mg, full numbers, ask me anything boring. The relevant figures are 55 weeks and 5mg, and they come from the same log I have kept the whole time. Holding off on any opinion until phase 3 reports. That is not a satisfying position and it is the honest one. Why "oral" is doing two completely…

Read the full submission and all 10 comments →

This branch

6 comments, started 3 months ago
u/hedda_ekstrom17 points·3 months ago

Analytically this is a small-molecule identity and purity problem, not a peptide one. The methods, the impurity classes and the reference standards are all different.

replysharereportpermalink
u/lucia_bruun4 points·3 months ago

nothing containing this is approved anywhere and research material is not for human use

replysharereportpermalink
u/kenji_kimani1 point·3 months ago

Read both programme names carefully after mixing them up in a comment and being politely corrected.

replysharereportpermalink
u/viktor_laurent1 point·3 months ago

Correction: that is the oral peptide product, which is a different thing entirely. This one is a small molecule.

replysharereportpermalink
u/tidy_vialdrawer_watch28OP1 point·3 months ago

Went looking for independent testing on this and found essentially nothing, which was clarifying.

replysharereportpermalink
u/joaquin_trevino-10 points·3 months ago

Push back: daily dosing is not automatically better adherence. It is a different failure mode, not a solved problem.

replysharereportpermalink

← back to the whole thread

About c/orforglipron

The small-molecule oral: why a non-peptide agonist escapes the absorption problems of oral semaglutide, what the ATTAIN and ACHIEVE readouts showed, and what a pill with no refrigeration requirement would do to the entire supply conversation this site is built around.

21kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.comSponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
More in c/orforglipron
c/orforglipron rules
  1. Small molecule, not a peptide. Purity discussion here is a different problem.
  2. Cite ATTAIN/ACHIEVE arms specifically when quoting numbers.
  3. Availability speculation must be flaired Speculation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/incretin_ivyu/phase_two_peteu/trialwatch_theo
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →